Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Milani

Showing results (1-10 of 382) with videos related to

Pageof 39
Sort By:
Best Practice & Research. Clinical Haematology|November 10, 2016
Monoclonal IgM-related AL amyloidosisPaolo Milani, Giampaolo Merlini
Acta Haematologica|May 1, 2020
Conventional Therapy for Amyloid Light-Chain AmyloidosisPaolo Milani, Giovanni Palladini
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|June 12, 2016
Intravitreal aflibercept for myopic choroidal neovascularizationAlfredo Pece, Paolo Milani
British Journal of Haematology|June 6, 2024
Response matters in light chain amyloidosis, whatever it takesGiovanni Palladini, Paolo Milani
Drugs|January 18, 2023
Diagnosis and Treatment of AL AmyloidosisGiovanni Palladini, Paolo Milani
Leukemia & Lymphoma|April 21, 2021
The quest for validated treatment endpoints in light chain (AL) amyloidosis: composite criteria for a composite diseaseGiovanni Palladini, Paolo Milani
Current Opinion in Oncology|August 9, 2022
Advances in the treatment of light chain amyloidosisGiovanni Palladini, Paolo Milani
Journal of the National Comprehensive Cancer Network : JNCCN|January 12, 2023
Individualized Approach to Management of Light Chain AmyloidosisGiovanni Palladini, Paolo Milani
Blood|December 3, 2020
Management of AL amyloidosis in 2020Giovanni Palladini, Paolo Milani, Giampaolo Merlini
Hematology. American Society of Hematology. Education Program|December 4, 2020
Management of AL amyloidosis in 2020Giovanni Palladini, Paolo Milani, Giampaolo Merlini
Pageof 39

Showing results (1-10 of 382) with videos related to

Sort By:
Pageof 39
Best Practice & Research. Clinical Haematology|November 10, 2016
Monoclonal IgM-related AL amyloidosisPaolo Milani, Giampaolo Merlini
Acta Haematologica|May 1, 2020
Conventional Therapy for Amyloid Light-Chain AmyloidosisPaolo Milani, Giovanni Palladini
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|June 12, 2016
Intravitreal aflibercept for myopic choroidal neovascularizationAlfredo Pece, Paolo Milani
British Journal of Haematology|June 6, 2024
Response matters in light chain amyloidosis, whatever it takesGiovanni Palladini, Paolo Milani
Drugs|January 18, 2023
Diagnosis and Treatment of AL AmyloidosisGiovanni Palladini, Paolo Milani
Leukemia & Lymphoma|April 21, 2021
The quest for validated treatment endpoints in light chain (AL) amyloidosis: composite criteria for a composite diseaseGiovanni Palladini, Paolo Milani
Current Opinion in Oncology|August 9, 2022
Advances in the treatment of light chain amyloidosisGiovanni Palladini, Paolo Milani
Journal of the National Comprehensive Cancer Network : JNCCN|January 12, 2023
Individualized Approach to Management of Light Chain AmyloidosisGiovanni Palladini, Paolo Milani
Blood|December 3, 2020
Management of AL amyloidosis in 2020Giovanni Palladini, Paolo Milani, Giampaolo Merlini
Hematology. American Society of Hematology. Education Program|December 4, 2020
Management of AL amyloidosis in 2020Giovanni Palladini, Paolo Milani, Giampaolo Merlini
Pageof 39